SEC Tracker
Get the app

Alector ALEC

Alector reprices stock options

Form
8-K
Filed
Importance
Routine
  1. Effective Date: October 13, 2026
  2. Repriced options: 4.05 million shares
  3. New exercise price: $1.87 per share
  4. Eligible options held by CEO and CFO

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Alector files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Protalix BioTherapeutics PLX public float $113M, Jun 30, 2025
  2. Fate Therapeutics FATE public float $113M, Jun 30, 2025
  3. Caribou Biosciences CRBU public float $113M, Jun 30, 2025
  4. Protara Therapeutics PRTO public float $112M, Jun 30, 2025
  5. TuHURA Biosciences HURA public float $111M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.